The immune microenvironment is composed of glioma-associated immune cells, such as microglia, macrophages, and B cells, and immunoregulatory factors, such as interleukin (IL)-6, IL-10, and transforming growth factor β (TGF-β), which regulate the progression of glioma (13). This evidence concerns the gene IL10 and central nervous system cancer.